Marker for psychiatric conditions
AssigneeRegents of the University of Minnesota
InventorS. Hossein Fatemi
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of Reelin as a marker for diagnosing psychiatric conditions. The disclosed tools and techniques can facilitate the diagnosis of psychiatric disorders including major depression, bipolar disorder, schizophrenia and autism.
Claims42
A method for diagnosing a psychiatric condition in a patient, said method comprising:
- comparing the level of at least one Reelin moiety in a biological sample from said patient with the level of a corresponding Reelin moiety in one or more control subjects;
- and
- diagnosing said psychiatric condition based on said comparing.
A method of diagnosing autism in an unborn child, said method comprising:
- comparing the level of at least one Reelin moiety in a biological sample from a biological parent or biological sibling of said unborn child with the level of a corresponding Reelin moiety in one or more control subjects;
- and
- diagnosing said autism based on said comparing.
An article of manufacture for diagnosing a psychiatric condition in a patient or in an unborn child, said article of manufacture comprising one or more anti- Reelin antibodies and packaging material, wherein said anti-Reelin antibodies can be used for determining Reelin levels in said patient or in the biological parents and/or a biological sibling of said unborn child, and wherein said packaging material comprises a label or package insert indicating that said anti-Reelin antibodies can be used for diagnosing said psychiatric condition.
Dependencies are inferred from the claim text.